Related Experiment Video
Updated: Aug 17, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Epidemiology of cardiovascular involvement in HIV disease and AIDS
1Department of Medicine, University of Rochester Medical Center and University of Rochester School of Medicine and Dentistry, New York 14642, USA.
Insights
Cardiac complications are common in people with HIV due to infection and treatment. Understanding these heart issues is crucial for effective monitoring and intervention, especially with new therapies.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Human Immunodeficiency Virus (HIV) infection impacts multiple organ systems.
- Cardiac complications are increasingly recognized in the HIV-infected population.
- Factors like chronic infection, co-infections, and antiretroviral therapy contribute to cardiovascular disease in HIV.
Purpose of the Study:
- To discuss the epidemiology of cardiac complications in HIV.
- To highlight the impact of HIV and its treatment on cardiovascular health.
- To emphasize the need for understanding cardiac manifestations for improved patient outcomes.
Main Methods:
- Review of existing literature on HIV-related cardiac complications.
- Discussion of various cardiac conditions associated with HIV.
- Analysis of contributing factors to cardiovascular disease in HIV.
Main Results:
- HIV infection is associated with a spectrum of cardiac issues, including cardiomyopathy, left ventricular hypertrophy, myocarditis, pericardial effusion, endocarditis, and malignancy.
- A significant increase in cardiac complications is projected for HIV-infected individuals.
- Cardiovascular effects are influenced by viral load, co-infections, and antiretroviral therapy.
Conclusions:
- Early recognition and understanding of cardiac complications in HIV are essential.
- Effective monitoring and intervention strategies are needed for HIV-associated heart disease.
- Further research is required to assess the long-term cardiovascular impact of novel HIV therapies.
Abstract:
The epidemiology of cardiac complications related to HIV including cardiomyopathy, increased left ventricular mass, myocarditis, pericardial effusion, endocarditis, and malignancy are discussed. A large number of HIV-infected individuals will present with cardiac complications in the next decade as chronic viral infection, co-infections, drug therapy, and immunosuppression affect the heart. Understanding the nature and course of cardiac illness related to HIV infection will allow appropriate monitoring, early intervention and therapy, and will provide a baseline to evaluate the effects of new therapeutic regimens such as highly active antiretroviral therapy on the cardiovascular system.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Infectious Diseases and Their Occurrence

